Telesis Bio, Inc. (TBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0530
+0.0020 (3.92%)
At close: May 29, 2026
Telesis Bio Market Cap
Telesis Bio has a market cap or net worth of $95.5 thousand as of May 29, 2026. Its market cap has decreased by -98.53% in one year.
Market Cap
95.50K
Enterprise Value
n/a
Revenue
17.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since June 18, 2021, Telesis Bio's market cap has decreased from 522.24M to 95.50K, a decrease of -99.98%. That is a compound annual growth rate of -82.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 95.50K | 6.00% |
| Dec 31, 2025 | 90.09K | -87.32% |
| Dec 31, 2024 | 710.34K | -94.06% |
| Dec 29, 2023 | 11.96M | -66.23% |
| Dec 30, 2022 | 35.43M | -88.81% |
| Dec 31, 2021 | 316.52M | -39.39% |
| Jun 18, 2021 | 522.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nu-Med Plus | 852.19K |
| IR-Med | 780.14K |
| STRATA Skin Sciences | 773.12K |
| Electromedical Technologies | 746.46K |
| ECGI Holdings | 326.50K |
| Rafina Innovations | 138.98K |
| Verisante Technology | 92.27K |
| Pressure BioSciences | 51.56K |